Selecting patients with rectal cancer for total neoadjuvant therapy based on clinical lymph node status: do we dare?

Bahadoer RR, Dijkstra EA, van Etten B, Marijnen CAM, Putter H, Kranenbarg EMK, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29–42.

https://doi.org/10.1016/S1470-2045(20)30555-6 DOI: https://doi.org/10.1016/S1470-2045(20)30555-6

Conroy T, Castan F, Etienne PL, Rio E, Mesgouez-Nebout N, Evesque L, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial. Ann Oncol. 2024;35(10):873–81.

https://doi.org/10.1016/j.annonc.2024.06.019 DOI: https://doi.org/10.1016/j.annonc.2024.06.019

Hofheinz RD, Fokas E, Benhaim L, Price TJ, Arnold D, Beets-Tan R, et al. Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2025;36(9):1007–24.

https://doi.org/10.1016/j.annonc.2025.05.528 DOI: https://doi.org/10.1016/j.annonc.2025.05.528

Liu S, Jiang T, Xiao L, Yang S, Liu Q, Gao Y, et al. Total neoadjuvant therapy (TNT) versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis. Oncologist. 2021;26(9):e1555–66.

https://doi.org/10.1002/onco.13824 DOI: https://doi.org/10.1002/onco.13824

Eng C, Yoshino T, Ruíz-García E, Mostafa N, Cann CG, O’Brian B, et al. Colorectal cancer. Lancet. 2024;404(10449):294–310.

https://doi.org/10.1016/S0140-6736(24)00360-X DOI: https://doi.org/10.1016/S0140-6736(24)00360-X

Brouwer NPM, Stijns RCH, Lemmens VEPP, Nagtegaal ID, Beets-Tan RGH, Fütterer JJ, et al. Clinical lymph node staging in colorectal cancer; a flip of the coin? Eur J Surg Oncol. 2018;44(8):1241–6.

https://doi.org/10.1016/j.ejso.2018.04.008 DOI: https://doi.org/10.1016/j.ejso.2018.04.008

Elm EV, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbrouckef JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;85(11):867–72. DOI: https://doi.org/10.2471/BLT.07.045120

https://doi.org/10.1136/bmj.39335.541782.AD DOI: https://doi.org/10.1136/bmj.39335.541782.AD

Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018;28(4):1465–75.

https://doi.org/10.1007/s00330-017-5026-2 DOI: https://doi.org/10.1007/s00330-017-5026-2

Horvat N, Rocha CCT, Oliveira B, Petkovska I, Gollub MJ. MRI of rectal cancer: tumor staging, imaging techniques, and management. Radiographics. 2019;39(2):367–87.

https://doi.org/10.1148/rg.2019180114 DOI: https://doi.org/10.1148/rg.2019180114

Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel C, Cervantes A, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(Suppl. 4):iv72–83.

https://doi.org/10.1093/annonc/mdx224 DOI: https://doi.org/10.1093/annonc/mdx224

Klein MF, Gögenur I, Ingeholm P, Njor SH, Iversen LH, Emmertsen KJ, et al. Validation of the Danish Colorectal Cancer Group (DCCG.dk) database – on behalf of the Danish Colorectal Cancer Group. Colorectal Dis. 2020;22(12):2057–67.

https://doi.org/10.1111/codi.15352 DOI: https://doi.org/10.1111/codi.15352

R Core Team. R: a language and environment for statistical computing [Internet]. Vienna: R Foundation for Statistical Computing; 2025. [cited 2025 November 20]. Available from: https://www.R-project.org

Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003;227(2):371–7.

https://doi.org/10.1148/radiol.2272011747 DOI: https://doi.org/10.1148/radiol.2272011747

Gröne J, Loch FN, Taupitz M, Schmidt C, Kreis ME. Accuracy of various lymph node staging criteria in rectal cancer with magnetic resonance imaging. J Gastrointest Surg. 2018;22(1):146–53.

https://doi.org/10.1007/s11605-017-3568-x DOI: https://doi.org/10.1007/s11605-017-3568-x

Zhuang Z, Zhang Y, Wei M, Yang X, Wang Z. Magnetic resonance imaging evaluation of the accuracy of various lymph node staging criteria in rectal cancer: a systematic review and meta-analysis. Front Oncol. 2021;11:709070.

https://doi.org/10.3389/fonc.2021.709070 DOI: https://doi.org/10.3389/fonc.2021.709070

Danihel ML, Daniel L, Rajcok M, Mosna K, Belan V, Varga I, et al. Significance of MRI in rectal carcinoma therapy optimization – correlation of preoperative T- and N-staging with definitive histopathological findings. Neoplasma. 2013;60(5):607–16.

Fritz S, Killguss H, Schaudt A, Lazarou L, Sommer CM, Richter GM, et al. Preoperative versus pathological staging of rectal cancer – challenging the indication of neoadjuvant chemoradiotherapy. Int J Colorectal Dis. 2021;36(1):191–4.

https://doi.org/10.1007/s00384-020-03751-3 DOI: https://doi.org/10.1007/s00384-020-03751-3

Lord AC, Corr A, Chandramohan A, Hodges N, Pring E, Airo-Farulla C, et al. Assessment of the 2020 NICE criteria for preoperative radiotherapy in patients with rectal cancer treated by surgery alone in comparison with proven MRI prognostic factors: a retrospective cohort study. Lancet Oncol. 2022;23(6):793–801.

https://doi.org/10.1016/S1470-2045(22)00214-5 DOI: https://doi.org/10.1016/S1470-2045(22)00214-5

Quirke P, Steele R, Monson J, Grieve R, Khanna S, Couture J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373(9666):821–8.

https://doi.org/10.1016/S0140-6736(09)60485-2 DOI: https://doi.org/10.1016/S0140-6736(09)60485-2

Taylor FGM, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol. 2014;32(1):34–43.

https://doi.org/10.1200/JCO.2012.45.3258 DOI: https://doi.org/10.1200/JCO.2012.45.3258

Poulsen LØ, Yilmaz MK, Oddershede L, Bøgsted M, Holt G, Eld M, et al. Is the accuracy of preoperative MRI stage in rectal adenocarcinoma influenced by tumour height? Acta Oncol. 2018;57(6):728–34.

https://doi.org/10.1080/0284186X.2018.1433319 DOI: https://doi.org/10.1080/0284186X.2018.1433319

Ben Dhia S, Chauvière D, Mitrea D, Schiappa R, Pace Loscos T, Chamorey E, et al. Organ preservation, for rectal cancer: general overview of the latest data from phase III randomized trials. Acta Oncol. 2025;64:120–8.

https://doi.org/10.2340/1651-226X.2025.41057 DOI: https://doi.org/10.2340/1651-226X.2025.41057

Conroy T, Bosset JF, Etienne PL, Rio E, François É, Mesgouez-Nebout N, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(5):702–15.

https://doi.org/10.1016/S1470-2045(21)00079-6 DOI: https://doi.org/10.1016/S1470-2045(21)00079-6